EVIDENCE-GUIDED OPTIMIZATION OF HERBAL FORMULA CHEONG-HWA-BO-UM-TANG USING MULTIPLEX CYTOKINE PROFILING
DOI:
https://doi.org/10.21010/ajtcam.v13i2.9Keywords:
Cheong-Hwa-Bo-Um-Tang, Lipopolysaccharide, Inflammation, Macrophages, Cytokine, Nitric OxideAbstract
Background: Cheong-Hwa-Bo-Um-Tang (CHB) has been traditionally used to treat pharyngolaryngitis and throat inflammation in Korea. However, the anti-inflammatory activity of CHB and the exact component proportion ratio of CHB have not been fully reported. Materials and Methods: This study was conducted to optimize the component proportion ratio of CHB on the basis of experimental evidence using multiplex cytokine profiling assay in LPS-stimulated RAW 264.7 mouse macrophages. Results: The optimized CHB (named Chunhwabun-Cheong-Hwa-Bo-Um-Tang) inhibited the production of NO, IL-6, MCP-1, GMCSF, IL-10, IP-10, VEGF, M-CSF, RANTES, MIP-1β, LIF, LIX, and TNF-α in LPS-stimulated RAW 264.7 mouse macrophages without decreasing cell viability (P<0.05). Chunhwabun-Cheong-Hwa-Bo-Um-Tang consisted of roots of Scrophularia buergeriana, Trichosanthes kirilowii, Anemarrhena asphodeloides, Phellodendron amurense, Angelica gigas, Rehmannia glutinosa, Paeonia japonica, Cnidium officinale, and Glycyrrhiza uralensis (in the ratio of 8: 3: 3: 3: 3: 4: 4: 3: 3). Conclusion: The results of this study indicate that the multiplex cytokine profiling assay could be one of the effective methods for evidence-guided optimization of the component proportion ratio of a traditional herbal formula used for treating excessive inflammation such as the cytokine storm.Downloads
Published
How to Cite
Issue
Section
License
Copyright: Creative Commons Attribution CC.
This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. View License Deed | View Legal Code Authors can also self-archive their manuscripts immediately and enable public access from their institution's repository. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications.